EcoR1 Capital, LLC Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$2.9T
Holdings
80
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (80 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PRTAPROTHENA CORP PLC | 11,584,280 | $314.5B | 10.86% | |
| 2 | APLSAPELLIS PHARMACEUTICALS INC | 5,183,431 | $234.4B | 8.09% | |
| 3 | SRPTSAREPTA THERAPEUTICS INC | 2,868,145 | $215.0B | 7.42% | |
| 4 | SGENUSDSEAGEN INC | 1,008,628 | $178.5B | 6.16% | |
| 5 | GLPGGALAPAGOS NV | 3,197,500 | $178.4B | 6.16% | |
| 6 | ANABANAPTYSBIO INC | 7,521,024 | $152.7B | 5.27% | |
| 7 | XNCRXENCOR INC | 5,282,416 | $144.6B | 4.99% | |
| 8 | ARVNARVINAS INC | 3,123,300 | $131.5B | 4.54% | |
| 9 | KURAKURA ONCOLOGY INC | 6,638,371 | $121.7B | 4.20% | |
| 10 | MORFMORPHIC HLDG INC | 3,951,566 | $85.7B | 2.96% | |
| 11 | ACADACADIA PHARMACEUTICALS INC | 5,991,479 | $84.4B | 2.91% | |
| 12 | ZLABZAI LAB LT | 2,431,885 | $84.3B | 2.91% | |
| 13 | RVMDREVOLUTION MEDICINES INC | 4,278,069 | $83.4B | 2.88% | |
| 14 | RLAYRELAY THERAPEUTICS INC | 3,723,541 | $62.4B | 2.15% | |
| 15 | RETAEURREATA PHARMACEUTICALS INC | 1,975,611 | $60.0B | 2.07% | |
| 16 | ALLOALLOGENE THERAPEUTICS INC | 4,488,200 | $51.2B | 1.77% | |
| 17 | ARGXARGENX SE | 125,000 | $47.4B | 1.63% | |
| 18 | TSVT*2SEVENTY BIO INC | 3,495,943 | $46.1B | 1.59% | |
| 19 | NUVBNUVATION BIO INC | 13,896,543 | $45.0B | 1.55% | |
| 20 | AVIRATEA PHARMACEUTICALS INC | 6,340,639 | $45.0B | 1.55% | |
| 21 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 1,646,260 | $43.5B | 1.50% | |
| 22 | ALECALECTOR INC | 4,056,548 | $41.2B | 1.42% | |
| 23 | RNAAVIDITY BIOSCIENCES INC | 2,759,505 | $40.1B | 1.38% | |
| 24 | DSGNDESIGN THERAPEUTICS INC | 2,634,178 | $36.9B | 1.27% | |
| 25 | VYGRVOYAGER THERAPEUTICS INC | 4,753,907 | $28.1B | 0.97% | |
| 26 | CRNXCRINETICS PHARMACEUTICALS IN | 1,330,263 | $24.8B | 0.86% | |
| 27 | GONGERON CORP | 14,168,988 | $22.0B | 0.76% | |
| 28 | ARQTARCUTIS BIOTHERAPEUTICS INC | 895,503 | $19.1B | 0.66% | |
| 29 | EWTXEDGEWISE THERAPEUTICS INC | 2,359,808 | $18.8B | 0.65% | |
| 30 | JANXJANUX THERAPEUTICS INC | 1,421,319 | $17.4B | 0.60% | |
| 31 | VTYXVENTYX BIOSCIENCES INC | 1,300,000 | $15.9B | 0.55% | |
| 32 | EX9EXELIXIS INC | 760,000 | $15.8B | 0.55% | Call |
| 33 | ORICORIC PHARMACEUTICALS INC | 3,418,068 | $15.3B | 0.53% | |
| 34 | CGEMCULLINAN ONCOLOGY INC | 1,169,889 | $15.0B | 0.52% | |
| 35 | INCYINCYTE CORP | 182,783 | $13.9B | 0.48% | |
| 36 | OVIDOVID THERAPEUTICS INC | 6,117,400 | $13.2B | 0.45% | |
| 37 | 290ACHINOOK THERAPEUTICS INC | 690,000 | $12.1B | 0.42% | |
| 38 | GRCLGRACELL BIOTECHNOLOGIES INC | 1,921,310 | $10.6B | 0.36% | |
| 39 | TNGXTANGO THERAPEUTICS INC | 2,302,065 | $10.4B | 0.36% | |
| 40 | —AKOUOS INC | 1,975,984 | $9.3B | 0.32% | |
| 41 | HOOKGBPHOOKIPA PHARMA INC | 5,000,000 | $8.2B | 0.28% | |
| 42 | DTILPRECISION BIOSCIENCES INC | 5,035,971 | $8.1B | 0.28% | |
| 43 | SURFUSDSURFACE ONCOLOGY INC | 4,653,000 | $7.6B | 0.26% | |
| 44 | NGMUSDNGM BIOPHARMACEUTICALS INC | 541,108 | $6.9B | 0.24% | |
| 45 | —FRAZIER LIFESCIENCES ACQU CO | 587,615 | $5.8B | 0.20% | |
| 46 | 5E7ITEOS THERAPEUTICS INC | 279,999 | $5.8B | 0.20% | |
| 47 | —JIYA ACQUISITION CORP | 500,000 | $4.9B | 0.17% | |
| 48 | ALGSALIGOS THERAPEUTICS INC | 3,948,360 | $4.8B | 0.16% | |
| 49 | SELBUSDSELECTA BIOSCIENCES INC | 3,500,000 | $4.6B | 0.16% | |
| 50 | 0HJQAVEO PHARMACEUTICALS INC | 647,489 | $4.2B | 0.15% | |
| 51 | —HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.0B | 0.14% | |
| 52 | ERASERASCA INC | 678,441 | $3.8B | 0.13% | |
| 53 | GRPHGRAPHITE BIO INC | 1,162,179 | $3.2B | 0.11% | |
| 54 | NUVB/WSNUVATION BIO INC | 963,333 | $3.1B | 0.11% | |
| 55 | TCE2CELLDEX THERAPEUTICS INC NEW | 115,200 | $3.1B | 0.11% | Put |
| 56 | SPRYSILVERBACK THERAPEUTICS INC | 575,359 | $2.4B | 0.08% | |
| 57 | OVASUSDTEMPEST THERAPEUTICS INC | 1,031,268 | $2.2B | 0.08% | |
| 58 | —KINNATE BIOPHARMA INC | 175,000 | $2.2B | 0.08% | |
| 59 | —BCLS ACQUISITION CORP | 200,000 | $2.0B | 0.07% | |
| 60 | —EUCRATES BIOMEDICAL ACQU COR | 200,000 | $2.0B | 0.07% | |
| 61 | —5 01 ACQUISITION CORP | 200,000 | $2.0B | 0.07% | |
| 62 | VERVVERVE THERAPEUTICS INC | 98,593 | $1.5B | 0.05% | |
| 63 | DYNDYNE THERAPEUTICS INC | 215,000 | $1.5B | 0.05% | |
| 64 | —ARYA SCIENCES ACQU CORP IV | 150,000 | $1.5B | 0.05% | |
| 65 | OLMAOLEMA PHARMACEUTICALS INC | 353,701 | $1.4B | 0.05% | |
| 66 | —MERSANA THERAPEUTICS INC | 310,960 | $1.4B | 0.05% | |
| 67 | CNTACENTESSA PHARMACEUTICALS PLC | 292,320 | $1.4B | 0.05% | |
| 68 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 1,046,700 | $1.3B | 0.04% | |
| 69 | KRON1USDKRONOS BIO INC | 326,780 | $1.2B | 0.04% | |
| 70 | —TURMERIC ACQUISITION CORP | 100,000 | $993.0M | 0.03% | |
| 71 | —EUCRATES BIOMEDICAL ACQU COR | 66,666 | $660.0M | 0.02% | |
| 72 | —FRAZIER LIFESCIENCES ACQU CO | 66,665 | $658.0M | 0.02% | |
| 73 | —PARDES BIOSCIENCES INC | 200,000 | $614.0M | 0.02% | |
| 74 | PRAXPRAXIS PRECISION MEDICINES I | 210,100 | $515.0M | 0.02% | |
| 75 | —OMEGA ALPHA SPAC | 50,000 | $493.0M | 0.02% | |
| 76 | —EVELO BIOSCIENCES INC | 200,417 | $423.0M | 0.01% | |
| 77 | —CAREMAX INC | 100,000 | $363.0M | 0.01% | |
| 78 | —TURMERIC ACQUISITION CORP | 33,333 | $331.0M | 0.01% | |
| 79 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 150,000 | $306.0M | 0.01% | |
| 80 | SRZNWSURROZEN INC | 66,665 | $200.0M | 0.01% |